SynthesisBMC pediatrics2026
Prevalence of sight-threatening ocular abnormalities identified by retinal examination in neonates: a systematic review and meta-analysis.
Synthesis in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRed reflex testing for newborn screening detects only a fifth of disorders requiring intervention. In this systematic review and meta-analysis, we assessed the prevalence of sight-threatening disorders detected by screening newborn babies with retinal examination.
methodsWe searched PubMed, Embase, Web of Science and Scopus databases for studies assessing newborn retinal examination and reporting treatable sight-threatening abnormalities (cataract, glaucoma and retinoblastoma) and treatable potentially sight-threatening abnormalities (retinitis, vitreous hemorrhage, ROP-like retinopathy and familial exudative vitreoretinopathy). We excluded studies on preterm neonates reporting only ROP and on term neonates reporting only retinal hemorrhages. We adhered to MOOSE guidelines and used the JBI tool for quality assessment and R software for analysis (double arcsine transformation model).
resultsThirteen observational studies (250,513 neonates) published between 2015 and 2024 were included in the meta-analysis. The studies were from China, India, Brazil, Malaysia, Indonesia, Turkey and New Zealand. Eleven studies used wide-field retinal imaging by RetCam and its variants, and one study each used indirect ophthalmoscopy and smartphone-based fundus imaging devices. On quality assessment, five studies were at increased risk of bias due to small sample size and/or not including consecutive births. The prevalence of treatable sight-threatening abnormalities was 6.1 per 10,000 neonates (13 studies, 250,513 neonates, 95% CI: 1, 14.1), and the prevalence of treatable potentially sight-threatening abnormalities was 42.2 per 10,000 neonates (12 studies, 250,167 neonates, 95% CI: 19.8, 71.9). No adverse effects were reported.
conclusionsEye screening of neonates with retinal examination can detect several sight-threatening abnormalities amenable to intervention.
trial registrationPROSPERO database with registration number CRD42023448129.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.